| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.42 | 0.0003 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.25 | 0.002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |